Vermillion Company Profile (NASDAQ:VRML)

About Vermillion (NASDAQ:VRML)

Vermillion logoVermillion, Inc. is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor prior to planned surgery. It developed OVA1 through pre-clinical studies in collaboration with various academic medical centers encompassing over 2,500 clinical samples. OVA1 is validated in a multi-center clinical trial encompassing approximately 30 sites reflective of the diverse nature of the clinical centers, at which ovarian adnexal masses are evaluated. Its ASPiRA LABS is a laboratory that provides diagnostic services using a biomarker-based diagnostic algorithm to inform clinical decision making and personalized treatment plans.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Diagnostics & Testing
  • Sub-Industry: N/A
  • Symbol: NASDAQ:VRML
  • CUSIP: N/A
  • Web: www.vermillion.com
Capitalization:
  • Market Cap: $75.82 million
  • Outstanding Shares: 56,164,000
Average Prices:
  • 50 Day Moving Avg: $1.34
  • 200 Day Moving Avg: $1.74
  • 52 Week Range: $0.76 - $2.85
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.44
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $3.05 million
  • Price / Sales: 24.86
  • Book Value: $0.08 per share
  • Price / Book: 16.88
Profitability:
  • EBIDTA: ($10,500,000.00)
  • Net Margins: -372.05%
  • Return on Equity: -215.26%
  • Return on Assets: -121.77%
Debt:
  • Debt-to-Equity Ratio: 0.34%
  • Current Ratio: 3.21%
  • Quick Ratio: 3.16%
Misc:
  • Average Volume: 40,223 shs.
  • Beta: 2.42
  • Short Ratio: 16.56
 

Frequently Asked Questions for Vermillion (NASDAQ:VRML)

What is Vermillion's stock symbol?

Vermillion trades on the NASDAQ under the ticker symbol "VRML."

How were Vermillion's earnings last quarter?

Vermillion, Inc. (NASDAQ:VRML) announced its quarterly earnings results on Wednesday, August, 9th. The company reported ($0.04) EPS for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.04). The company had revenue of $0.90 million for the quarter. Vermillion had a negative net margin of 372.05% and a negative return on equity of 215.26%. View Vermillion's Earnings History.

Where is Vermillion's stock going? Where will Vermillion's stock price be in 2017?

1 equities research analysts have issued 12 month target prices for Vermillion's shares. Their forecasts range from $1.75 to $1.75. On average, they anticipate Vermillion's stock price to reach $1.75 in the next year. View Analyst Ratings for Vermillion.

Who are some of Vermillion's key competitors?

Who are Vermillion's key executives?

Vermillion's management team includes the folowing people:

  • James T. LaFrance, Chairman of the Board
  • Valerie Barber Palmieri, President, Chief Executive Officer
  • Fred Ferrara, Chief Operating Officer
  • Donald G. Munroe Ph.D., Senior Vice President - Business Development, Chief Scientific Officer
  • Eric J. Schoen, Chief Accounting Officer, Vice President - Finance
  • James S. Burns, Independent Director
  • Veronica G. H. Jordan Ph.D., Independent Director
  • David R Schreiber, Independent Director
  • Carl Severinghaus, Independent Director
  • Eric K. Varma M.D., Independent Director

Who owns Vermillion stock?

Vermillion's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include FMR LLC (9.36%), Birchview Capital LP (4.07%), Vanguard Group Inc. (1.03%), Cannell Peter B & Co. Inc. (0.60%), M&T Bank Corp (0.41%) and Trellus Management Company LLC (0.21%). Company insiders that own Vermillion stock include Eric Schoen, Jack W Schuler, Larry N Feinberg, Valerie Barber Palmieri and Veronica Gh Jordan. View Institutional Ownership Trends for Vermillion.

Who sold Vermillion stock? Who is selling Vermillion stock?

Vermillion's stock was sold by a variety of institutional investors in the last quarter, including Birchview Capital LP and Trellus Management Company LLC. View Insider Buying and Selling for Vermillion.

Who bought Vermillion stock? Who is buying Vermillion stock?

Vermillion's stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc.. Company insiders that have bought Vermillion stock in the last two years include Eric Schoen, Jack W Schuler, Larry N Feinberg, Valerie Barber Palmieri and Veronica Gh Jordan. View Insider Buying and Selling for Vermillion.

How do I buy Vermillion stock?

Shares of Vermillion can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vermillion's stock price today?

One share of Vermillion stock can currently be purchased for approximately $1.35.


MarketBeat Community Rating for Vermillion (NASDAQ VRML)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  68 (Vote Outperform)
Underperform Votes:  47 (Vote Underperform)
Total Votes:  115
MarketBeat's community ratings are surveys of what our community members think about Vermillion and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Vermillion (NASDAQ:VRML) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $1.75 (29.63% upside)

Analysts' Ratings History for Vermillion (NASDAQ:VRML)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/30/2017Canaccord GenuityReiterated RatingBuy$2.50 -> $1.75LowView Rating Details
(Data available from 9/25/2015 forward)

Earnings

Earnings History for Vermillion (NASDAQ:VRML)
Earnings by Quarter for Vermillion (NASDAQ:VRML)
Earnings History by Quarter for Vermillion (NASDAQ VRML)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2017Q2 2017($0.04)($0.04)$0.90 millionViewListenView Earnings Details
5/18/2017Q1 2017($0.04)($0.05)$0.73 millionViewN/AView Earnings Details
11/10/2016Q316($0.06)($0.07)$0.62 millionViewN/AView Earnings Details
8/10/2016Q216($0.09)($0.07)$0.71 millionViewListenView Earnings Details
5/16/2016Q116($0.09)($0.09)$0.51 millionViewListenView Earnings Details
3/24/2016Q415($0.10)$1.20 million$0.36 millionViewListenView Earnings Details
11/12/2015Q315($0.10)($0.10)$0.57 million$0.33 millionViewListenView Earnings Details
8/13/2015Q215($0.08)($0.11)$1.50 million$535.00 millionViewListenView Earnings Details
5/11/2015Q115($0.10)($0.10)$0.81 million$0.95 millionViewListenView Earnings Details
3/25/2015Q414($0.08)($0.11)$1.59 million$1.57 millionViewListenView Earnings Details
11/14/2013Q3($0.10)$319.00 million$330.00 millionViewListenView Earnings Details
8/14/2013Q2 2013($0.11)$0.32 million$0.23 millionViewListenView Earnings Details
5/15/2013Q1 2013($0.15)($0.17)$0.30 million$0.33 millionViewListenView Earnings Details
11/12/2012Q312($0.21)($0.13)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Vermillion (NASDAQ:VRML)
Current Year EPS Consensus Estimate: $-0.16 EPS
Next Year EPS Consensus Estimate: $-0.16 EPS

Dividends

Dividend History for Vermillion (NASDAQ:VRML)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Vermillion (NASDAQ:VRML)
Insider Ownership Percentage: 3.67%
Institutional Ownership Percentage: 35.57%
Insider Trades by Quarter for Vermillion (NASDAQ:VRML)
Institutional Ownership by Quarter for Vermillion (NASDAQ:VRML)
Insider Trades by Quarter for Vermillion (NASDAQ:VRML)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2017Valerie Barber PalmieriInsiderBuy719$1.39$999.41View SEC Filing  
8/23/2017Valerie Barber PalmieriInsiderBuy768$1.30$998.40View SEC Filing  
5/17/2017Valerie Barber PalmieriInsiderBuy555$1.80$999.00View SEC Filing  
2/17/2017Larry N FeinbergInsiderBuy617,731$1.40$864,823.40View SEC Filing  
2/13/2017Eric SchoenSVPBuy3,347$1.40$4,685.80View SEC Filing  
2/13/2017Jack W SchulerMajor ShareholderBuy974,081$1.40$1,363,713.40View SEC Filing  
2/13/2017Valerie Barber PalmieriCEOBuy10,042$1.40$14,058.80View SEC Filing  
2/13/2017Veronica Gh JordanDirectorBuy6,695$1.40$9,373.00View SEC Filing  
1/28/2016Jack W SchulerMajor ShareholderBuy1,493$1.60$2,388.80View SEC Filing  
1/25/2016Jack W SchulerMajor ShareholderBuy3,700$1.57$5,809.00View SEC Filing  
1/21/2016Jack W SchulerMajor ShareholderBuy30,700$1.46$44,822.00View SEC Filing  
1/19/2016Jack W SchulerMajor ShareholderBuy57,749$1.45$83,736.05View SEC Filing  
1/15/2016Jack W SchulerMajor ShareholderBuy8,400$1.56$13,104.00View SEC Filing  
7/14/2015Larry N FeinbergInsiderBuy512,043$1.96$1,003,604.28View SEC Filing  
12/23/2014Jack W SchulerMajor ShareholderBuy1,288,339$1.44$1,855,208.16View SEC Filing  
12/23/2014Larry N FeinbergInsiderBuy972,222$1.44$1,399,999.68View SEC Filing  
12/19/2014Peter S RoddyDirectorBuy16,502$1.44$23,762.88View SEC Filing  
11/21/2014Valerie Barber PalmieriCOOBuy3,500$1.51$5,285.00View SEC Filing  
11/20/2014James T LafranceInsiderBuy27,907$1.44$40,186.08View SEC Filing  
11/20/2014Valerie Barber PalmieriCOOBuy30,000$1.44$43,200.00View SEC Filing  
11/19/2014James T LafranceInsiderBuy41,615$1.43$59,509.45View SEC Filing  
11/18/2014Eric SchoenCAOBuy5,000$1.42$7,100.00View SEC Filing  
11/20/2013William B CreechVPBuy2,000$2.33$4,660.00View SEC Filing  
6/11/2013William B CreechVPBuy10,000$3.18$31,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Vermillion (NASDAQ:VRML)
Latest Headlines for Vermillion (NASDAQ:VRML)
Source:
DateHeadline
finance.yahoo.com logoIs It Too Late To Buy Vermillion Inc (VRML)?
finance.yahoo.com - September 23 at 10:49 AM
finance.yahoo.com logoETFs with exposure to Vermillion, Inc. : September 19, 2017
finance.yahoo.com - September 19 at 8:30 PM
finance.yahoo.com logoVermillion, Inc. :VRML-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 19 at 9:22 AM
finance.yahoo.com logoVermillion and ASPiRA Labs Kick Off Ovarian Cancer Awareness Month with 100,000th Patient Test Milestone and Ringing the Nasdaq Opening Bell
finance.yahoo.com - September 1 at 10:56 AM
americanbankingnews.com logoVermillion, Inc. (VRML) Receives "Buy" Rating from Canaccord Genuity
www.americanbankingnews.com - August 30 at 4:56 PM
americanbankingnews.com logoCritical Analysis: Vermillion (VRML) & CareDx (CDNA)
www.americanbankingnews.com - August 25 at 2:12 PM
americanbankingnews.com logoCareDx (CDNA) vs. Vermillion (VRML) Critical Comparison
www.americanbankingnews.com - August 18 at 10:46 AM
finance.yahoo.com logoEdited Transcript of VRML earnings conference call or presentation 9-Aug-17 8:30pm GMT
finance.yahoo.com - August 13 at 7:34 AM
americanbankingnews.com logoVermillion, Inc. (VRML) Releases Quarterly Earnings Results, Hits Estimates
www.americanbankingnews.com - August 10 at 6:21 PM
finance.yahoo.com logoVermillion Reports Second Quarter 2017 Results
finance.yahoo.com - August 10 at 9:32 AM
finance.yahoo.com logoVermillion Announces Date Change of Second Quarter 2017 Financial Results and Investor Conference Call
finance.yahoo.com - August 5 at 8:22 AM
finance.yahoo.com logoVermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th
finance.yahoo.com - August 2 at 8:35 AM
americanbankingnews.com logoFinancial Survey: Veracyte (VCYT) and Vermillion (NASDAQ:VRML)
www.americanbankingnews.com - August 1 at 8:46 AM
americanbankingnews.com logoAnalyzing Veracyte (VCYT) & Vermillion (VRML)
www.americanbankingnews.com - July 31 at 2:23 PM
americanbankingnews.com logoVermillion, Inc. (NASDAQ:VRML) Downgraded to "Sell" at ValuEngine
www.americanbankingnews.com - July 28 at 10:26 PM
finance.yahoo.com logoVermillion to Report Second Quarter 2017 Financial Results and Host Investor Conference Call on August 8th
finance.yahoo.com - July 28 at 9:47 AM
americanbankingnews.com logoVermillion (NASDAQ:VRML) vs. InVitae Corp (NVTA) Head-To-Head Survey
www.americanbankingnews.com - July 24 at 2:14 PM
americanbankingnews.com logoVermillion (VRML) vs. Lion Biotechnologies (IOVA) Head-To-Head Comparison
www.americanbankingnews.com - July 20 at 6:27 PM
americanbankingnews.com logo Vermillion, Inc. (NASDAQ:VRML) Receives Average Recommendation of "" from Analysts
www.americanbankingnews.com - July 17 at 8:14 PM
americanbankingnews.com logoCritical Survey: Vermillion (VRML) vs. InVitae Corp (NVTA)
www.americanbankingnews.com - July 14 at 12:08 AM
finance.yahoo.com logoETFs with exposure to Vermillion, Inc. : July 11, 2017
finance.yahoo.com - July 12 at 9:05 AM
americanbankingnews.com logoAffymetrix (AFFX) versus Vermillion (VRML) Critical Contrast
www.americanbankingnews.com - July 1 at 10:04 PM
americanbankingnews.com logoVermillion, Inc. (VRML) Upgraded at ValuEngine
www.americanbankingnews.com - June 2 at 8:04 PM
americanbankingnews.com logoVermillion, Inc. (VRML) Short Interest Up 10.5% in May
www.americanbankingnews.com - May 28 at 7:06 AM
finance.yahoo.com logoETFs with exposure to Vermillion, Inc. : May 15, 2017
finance.yahoo.com - May 15 at 7:44 PM
finance.yahoo.com logoVermillion, Inc. :VRML-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017
finance.yahoo.com - May 12 at 3:29 PM
americanbankingnews.com logoVermillion, Inc. (VRML) Issues Earnings Results
www.americanbankingnews.com - May 12 at 12:38 PM
finance.yahoo.com logoInvestor Network: Vermillion, Inc. to Host Earnings Call
finance.yahoo.com - May 12 at 4:13 AM
finance.yahoo.com logoVermillion Reports First Quarter 2017 Results
finance.yahoo.com - May 12 at 4:13 AM
finance.yahoo.com logoVermillion reports 1Q loss
finance.yahoo.com - May 12 at 4:13 AM
finance.yahoo.com logoEdited Transcript of VRML earnings conference call or presentation 11-May-17 12:30pm GMT
finance.yahoo.com - May 12 at 4:13 AM
americanbankingnews.com logoVermillion (VRML) Receiving Positive Press Coverage, Analysis Shows
www.americanbankingnews.com - May 3 at 3:52 PM
americanbankingnews.com logoVermillion, Inc. (VRML) Short Interest Update
www.americanbankingnews.com - April 29 at 7:06 AM
americanbankingnews.com logoVermillion (VRML) Getting Favorable Media Coverage, Report Shows
www.americanbankingnews.com - April 28 at 1:38 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Vermillion, Inc. - (VRML)
finance.yahoo.com - April 28 at 10:34 AM
finance.yahoo.com logoVermillion to Report First Quarter 2017 Financial Results and Host Investor Conference Call on May 11
finance.yahoo.com - April 26 at 5:09 PM
americanbankingnews.com logoSomewhat Negative News Coverage Extremely Likely to Affect Vermillion (VRML) Stock Price
www.americanbankingnews.com - April 25 at 3:30 PM
americanbankingnews.com logoVermillion (VRML) Getting Negative Media Coverage, Report Finds
www.americanbankingnews.com - April 19 at 8:23 AM
bizjournals.com logoAfter raising $2 million, Austin's Consortia Health tackles problems that might make some blush
www.bizjournals.com - April 15 at 7:00 PM
finance.yahoo.com logoETFs with exposure to Vermillion, Inc. : April 5, 2017
finance.yahoo.com - April 7 at 1:24 PM
biz.yahoo.com logoVERMILLION, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - April 1 at 9:38 AM
finance.yahoo.com logoEdited Transcript of VRML earnings conference call or presentation 29-Mar-17 8:30pm GMT
finance.yahoo.com - March 30 at 8:18 AM
finance.yahoo.com logoASPiRA Labs Announces TriCare South Contract
finance.yahoo.com - March 30 at 8:18 AM
biz.yahoo.com logoQ4 2016 Vermillion Inc Earnings Release - Before Market Open
biz.yahoo.com - March 29 at 10:17 AM
finance.yahoo.com logoVermillion Announces Publication of Ovarian Cancer Symptoms Index Study
finance.yahoo.com - March 29 at 10:17 AM
americanbankingnews.com logoVermillion, Inc. (VRML) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - March 28 at 8:23 AM
finance.yahoo.com logoVermillion to Report Fourth Quarter and Full Year 2016 Financial Results and Host Investor Conference Call on March 29, 2017
finance.yahoo.com - March 16 at 6:31 AM
biz.yahoo.com logoVERMILLION, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - March 13 at 8:09 PM
americanbankingnews.com logoVermillion, Inc. (VRML) Sees Large Decline in Short Interest
www.americanbankingnews.com - March 13 at 8:23 AM
finance.yahoo.com logoASPiRA LABs Announces Provider Status with Medi-Cal Expanding OVA1® Access to Over 12 Million Beneficiaries
finance.yahoo.com - March 6 at 7:53 PM

Social

Chart

Vermillion (VRML) Chart for Monday, September, 25, 2017

This page was last updated on 9/25/2017 by MarketBeat.com Staff